Lincoln Pharmaceuticals Ltd LINCOLN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 620.60
- Day Range
- INR 607.55–626.60
- 52-Week Range
- INR 383.80–755.15
- Bid/Ask
- INR 615.65 / INR 615.65
- Market Cap
- INR 12.33 Bil
- Volume/Avg
- 75,835 / 56,311
Key Statistics
- Price/Earnings (Normalized)
- 16.19
- Price/Sales
- 2.12
- Dividend Yield (Trailing)
- 0.24%
- Dividend Yield (Forward)
- 0.24%
- Total Yield
- 0.24%
Company Profile
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of Cardiac, Diabetic, Anti-malarial, Anti-biotic, Anti-fungal, Cephalosporin, Analgesic, Anaesthetics, Anti-pyretic, GIT products, Vitamin-Minerals, and Iron preparations. Geographically, the company carries out sales in India and outside India; generating key revenue from outside India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,700
- Website
- https://www.lincolnpharma.com
Comparables
Valuation
|
Metric
|
LINCOLN
|
524348
|
543434
|
|---|---|---|---|
Price/Earnings (Normalized) | 16.19 | 28.15 | 26.93 |
Price/Book Value | 2.08 | 3.74 | 3.93 |
Price/Sales | 2.12 | 1.89 | 5.62 |
Price/Cash Flow | 15.80 | 21.30 | 24.69 |
Price/Earnings
LINCOLN
524348
543434
Financial Strength
|
Metric
|
LINCOLN
|
524348
|
543434
|
|---|---|---|---|
Quick Ratio | 3.83 | 0.91 | 2.49 |
Current Ratio | 4.84 | 1.66 | 5.17 |
Interest Coverage | 84.45 | 8.03 | 79.53 |
Quick Ratio
LINCOLN
524348
543434
Profitability
|
Metric
|
LINCOLN
|
524348
|
543434
|
|---|---|---|---|
Return on Assets (Normalized) | 11.71% | 7.10% | 13.83% |
Return on Equity (Normalized) | 13.92% | 13.89% | 15.76% |
Return on Invested Capital (Normalized) | 14.09% | 10.74% | 15.72% |
Return on Assets
LINCOLN
524348
543434
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Pzqkwfbgc | Cylyc | $80.3 Bil | |||
| Zoetis Inc Class A
ZTS
| Dvkxrqwyv | Ntqm | $77.8 Bil | |||
| Haleon PLC ADR
HLN
| Rhhpffly | Jghdf | $37.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Zzxnkzpk | Ngxb | $12.1 Bil | |||
| Viatris Inc
VTRS
| Jycdztks | Dbs | $12.1 Bil | |||
| Catalent Inc
CTLT
| Yvssxtlg | Lfqckvn | $10.0 Bil | |||
| Perrigo Co PLC
PRGO
| Xjghvlz | Fhzpt | $3.7 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Gwtbxvbwj | Bkmckt | $3.2 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Fmwgcxyn | Hjnj | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Zxvcjvrpsn | Lsxy | $2.7 Bil |